Monash IVF Group 미래 성장

Future 기준 확인 4/6

Monash IVF Group (는) 각각 연간 48.4% 및 6.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 48.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13.5% 로 예상됩니다.

주요 정보

48.4%

수익 성장률

48.3%

EPS 성장률

Healthcare 수익 성장	23.7%
매출 성장률	6.3%
향후 자기자본 수익률	13.5%
애널리스트 커버리지	Good
마지막 업데이트	27 Nov 2024

최근 미래 성장 업데이트

Recent updates

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Nov 04

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

May 14

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Jun 06

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

May 25

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

May 13

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Mar 14

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Mar 04

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Feb 26

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

Feb 15

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

Feb 03

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Jan 22

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Jan 10

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

Dec 28

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Dec 17

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Dec 06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Nov 24

수익 및 매출 성장 예측

ASX:MVF - 애널리스트의 미래 추정치 및 과거 재무 데이터 (AUD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2027	309	36	47	60	7
6/30/2026	294	33	44	56	7
6/30/2025	277	31	39	23	7
6/30/2024	255	-7	31	53	N/A
3/31/2024	246	9	27	51	N/A
12/31/2023	236	24	22	49	N/A
9/30/2023	225	23	17	44	N/A
6/30/2023	214	22	11	39	N/A
3/31/2023	204	19	11	36	N/A
12/31/2022	195	17	11	33	N/A
9/30/2022	193	18	16	32	N/A
6/30/2022	192	18	20	32	N/A
3/31/2022	193	21	25	35	N/A
12/31/2021	194	23	30	38	N/A
9/30/2021	189	24	32	41	N/A
6/30/2021	184	25	34	44	N/A
3/31/2021	171	22	33	43	N/A
12/31/2020	159	18	31	41	N/A
9/30/2020	152	15	27	36	N/A
6/30/2020	145	12	24	31	N/A
3/31/2020	149	15	22	30	N/A
12/31/2019	152	18	20	28	N/A
9/30/2019	152	19	23	31	N/A
6/30/2019	152	20	27	33	N/A
3/31/2019	151	19	25	31	N/A
12/31/2018	151	19	24	29	N/A
9/30/2018	151	20	22	28	N/A
6/30/2018	151	21	19	26	N/A
3/31/2018	152	24	N/A	N/A	N/A
12/31/2017	153	26	N/A	29	N/A
9/30/2017	154	28	N/A	28	N/A
6/30/2017	155	30	N/A	26	N/A
3/31/2017	156	30	N/A	N/A	N/A
12/31/2016	156	30	N/A	34	N/A
9/30/2016	156	29	N/A	39	N/A
6/30/2016	157	29	N/A	44	N/A
3/31/2016	150	27	N/A	41	N/A
12/31/2015	144	24	N/A	38	N/A
9/30/2015	134	23	N/A	37	N/A
6/30/2015	125	21	N/A	36	N/A
3/31/2015	121	15	N/A	37	N/A
12/31/2014	117	8	N/A	38	N/A
9/30/2014	115	5	N/A	37	N/A
6/30/2014	114	3	N/A	36	N/A
3/31/2014	110	2	N/A	37	N/A

애널리스트 미래 성장 예측

수입 대 저축률: MVF 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.6% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: MVF (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: MVF 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: MVF 의 수익(연간 6.3% ) Australian 시장( 5.9% 보다 빠르게 성장할 것으로 예상됩니다. 5.9% 연간).

고성장 수익: MVF 의 수익(연간 6.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: MVF 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 13.5 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/01/03 07:17
장 마감 주가	2025/01/03 00:00
수익	2024/06/30
연간 수익	2024/06/30

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Monash IVF Group Limited 14 애널리스트 중 7 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Tara Speranza	Bell Potter
Martyn Jacobs	Bell Potter
David Stanton	CLSA

Monash IVF Group 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 7.3% to AU$1.42

Consensus forecasts updated

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 10%

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Price target increased to AU$1.08

Recent updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings: EPS misses analyst expectations

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Price target increased by 7.3% to AU$1.42

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Insufficient new directors

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Consensus forecasts updated

Upcoming dividend of AU$0.022 per share

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2022 earnings: EPS misses analyst expectations

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Consensus EPS estimates fall by 16%

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

Consensus EPS estimates fall by 10%

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Price target increased to AU$1.08

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Director recently bought AU$192k worth of stock

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Revenue and earnings beat expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Price target raised to AU$0.88

Analysts increase EPS estimates to AU$0.06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

New 90-day high: AU$0.71

Analysts increase EPS estimates to AU$0.053

Price target raised to AU$0.80